A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer von LLOMBART-CUSSAC, Antonio, MARTIN, Miguel, SIMMS, Lorinda, KAISER, Christopher J, MA, Doreen, HARBECK, Nadia, ANGHEL, Rodica M, ENIU, Alexandra E, VERRILL, Mark W, NEVEN, Patrick, DE GREVE, Jacques, MELEMED, Allen S, CLARK, Romnee

Volltext